Congenital heart disease and the risk of cancer: The importance of understanding associated comorbidities.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience.Pediatric blood & cancer · 2024
   Article
2. Comorbidities in congenital heart disease: different patterns in childhood and adulthood.BMC cardiovascular disorders · 2023
   Article
3. Cancer risk in adult congenital heart disease.International journal of cardiology. Congenital heart disease · 2023
   Review
4. Caring for the Aging Patient With Adult Congenital Heart Disease: A Review of Cardiac and Noncardiac Comorbidities.CJC pediatric and congenital heart disease · 2022
   Review
5. Evidence for reciprocal network interactions between injured hearts and cancer.Frontiers in cardiovascular medicine · 2022
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.